Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jieyu pill for epidemic-related stress, anxiety, and depression
ChiCTR2000039536Phase 4Recruiting
- Sponsor
- Beijing University of Chinese Medicine East Hospital
- Start
- Nov 2020
- Countries
- 1
01
Overview
Phase 4, open-label trial of Jieyu pill in anxiety disorder and major depressive disorder (MDD) (2 arms), sponsored by Beijing University of Chinese Medicine East Hospital. Primary endpoint: Hospital Anxiety and Depression Scale. Started Nov 2020; status: recruiting.
02
Drugs
Jieyu pill
03
Conditions
anxiety disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR2000039536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039536.